v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
May 31, 2025
May 31, 2024
Cash provided by operating activities:    
Net (loss) income $ (450,718) $ 6,204
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization 14,084 13,836
Amortization of financing costs 369 319
Non-cash operating lease expense 2,189 2,878
Provision for credit losses 621 88
Non-cash share-based compensation 296 5,833
Asset impairment charges 414,385 0
Gain on the sale or disposal of property and equipment (39) (29)
Deferred income taxes and tax credits (19,988) 10,445
Changes in operating capital, net of effects of acquisition of business:    
Receivables 114,092 64,595
Inventory (31,512) (48,754)
Prepaid expenses and other current assets (1,777) (3,565)
Other assets and liabilities, net (271) 327
Accounts payable (42,372) 2,350
Accrued expenses and other current liabilities 15,019 (19,465)
Accrued income taxes 43,960 (9,742)
Net cash provided by operating activities 58,338 25,320
Cash used by investing activities:    
Capital and intangible asset expenditures (13,362) (9,142)
Net proceeds from business acquired, net of cash acquired 3,880 0
Payments for purchases of U.S. Treasury Bills (687) (683)
Proceeds from the maturity of U.S. Treasury Bills 639 626
Proceeds from the sale of property and equipment 46 38
Net cash used by investing activities (9,484) (9,161)
Cash used by financing activities:    
Proceeds from revolving loans 131,500 314,040
Repayment of revolving loans (424,200) (230,090)
Proceeds from term loans 250,000 0
Repayment of long-term debt (2,344) (1,563)
Payment of financing costs (434) (222)
Proceeds from share issuances under share-based compensation plans 1,757 2,358
Payments for repurchases of common stock (1,331) (103,035)
Net cash used by financing activities (45,052) (18,512)
Net increase (decrease) in cash and cash equivalents 3,802 (2,353)
Cash and cash equivalents, beginning balance 18,867 18,501
Cash and cash equivalents, ending balance 22,669 16,148
Supplemental non-cash investing activity:    
Capital expenditures included in accounts payable and accrued expenses $ 6,670 $ 5,647